In this study, the effect of siGARP‐MSC exosomes on cell proliferation and invasion of MC38 cells was elucidated, and MSC‐derived exosomes targeting GARP could be used as a novel cancer therapy strategy for mouse colon cancer. Here, LRRC32 is linked to colonic neoplasm.